Xin Zhong

Zhong Xin, Bachelor of Biomedical Engineering from Tsinghua University, MS in Bioengineering, University of Michigan, Master of Electronic Engineering, worked as a senior engineer and project manager in the multimedia department of Qualcomm, USA. He has more than ten years of research and development of world-class intelligent electronic products. Technical experience and team management experience, including: deep learning, big data processing and data mining, computer vision, computer 3D graphics, speech recognition, digital camera imaging, etc. He studied business administration at the Carnegie Mellon University Business School from 2009 to 2010. After graduation, he worked in the Fixed Income Department of Morgan Stanley Bank, Goldman Sachs Bank Securities Trading Department, and Merrill Lynch Wealth Management Department. Inaugural, with advanced financial investment and management experience. After rejoining Qualcomm in 2013, he led the team in the development of deep neural networks, automatic scene recognition, object recognition, object tracking and handwriting recognition. He also serves as the manager of computer vision applications, focusing on smartphones, smart homes, security monitoring, biometrics, and smart car autopilots, successfully helping companies such as Xiaomi, OPPO, ZTE, and Samsung integrate object tracking technology into On the flagship smartphone. He has more than 20 international US and international technology patents, and has represented Qualcomm in consumer electronics exhibitions (CES), World Mobile Communications Exhibition (MWC), American Broadcasting Association Convention (NAB), etc. during 2013-‐2015. Exhibition of international trade shows. In April 2015, Zhong Xin and Dr. Gao Dashan, who worked at Qualcomm, co-founded 12 SIGMA TECHNOLOGIES, and independently developed a lung cancer nodule automatic identification and diagnosis system for clinical tomography, which was applied to machine learning and computer vision. A variety of cutting-edge technologies have shown good results in high-accuracy and high-reliability in early screening for lung cancer. Zhong Xin is the CEO of the company and is responsible for the company's commercial development and cooperation in China, the United States and overseas, and the development of domestic and foreign markets. The ultimate goal is to introduce the world's leading deep learning technology into all kinds of medical computer automatic diagnosis (CADe and CADx) and data analysis, combined with the internationally popular RIS, PACS and telemedicine platforms to achieve smart medical care.